Latest News

Breast cancer image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Sacituzumab govitecan-hziy

Brooke Kielkowski, PharmD, PGY2 Oncology Pharmacy Resident, and Jordan Hill, PharmD, BCOP, Pharmacy Clinical Specialist, both from WVU Medicine - West Virginia University Hospitals, Morgantown, WV, write about sacituzumab govitecan-hziy (Trodelvy).

stomach cancer image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Zolbetuximab-clzb

Olivia Tholt, PharmD, PGY2 Oncology Pharmacy Resident, and Sarah Cimino, PharmD, BCOP, Clinical Pharmacist Specialist, Gastrointestinal Oncology, both from Vanderbilt University Medical Center, Nashville, TN, write about zolbetuximab-clzb (Vyloy).

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Vorasidenib

Lacy La Fever, PharmD, MS, PGY2 Oncology Pharmacy Resident, and Anastasia Graham, PharmD, MBA, BCOP, Clinical Oncology Specialist, Neuro-oncology, both from Medical University of South Carolina, Charleston, SC, write about vorasidenib (Voranigo).

Image of breast cancer
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Inavolisib

Jessica Yoon, PharmD Candidate from Rutgers University, New Brunswick, NJ, and Grashma Vadakkel, PharmD, BCOP, Clinical Pharmacist at Memorial Sloan Kettering Cancer Center, New York, NY, write about inavolisib (Itovebi)..

Image of stem cell treatment
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Axatilimab-csfr

Sydney Hunt, PharmD, PGY-1 Pharmacist Resident, and Lindsay Orton, PharmD, BCOP, Stem Cell Transplant and Cellular Therapy Clinical Pharmacist, both from Vanderbilt University Medical Center, Nashville, TN, write about axatilimab-csfr (Niktimvo).

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Afamitresgene autoleucel

Emili Anderson, PharmD, PGY1 Acute Care Resident, and Roger Ngo, PharmD Candidate, both from UNC Medical Center, Chapel Hill, NC, write about afamitresgene autoleucel (afami-cel).

digital medical illustration of lung cancer in a person's chest
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Tarlatamab-dlle

SeongEun Emily Park, PharmD PGY2-Hematology/Oncology Pharmacy Resident Emory University Hospital Midtown/Winship Cancer Institute writes about tarlatamab-dlle.

red blood cells under a microscope with signs of cancer
Tools and Resources Drug Updates

Pharmacist's Application to Practice: imetelstat

Brian Lam, PharmD, PGY2 Oncology Pharmacy Resident at University of North Carolina, Chapel Hill, NC writes about imetelstat

Digital medical illustration of a bladder
Tools and Resources Drug Updates

Pharmacist's Application
to Practice: Nogapendekin
alfa inbakicept-pmln

Devan Parker, PharmD, PGY2 Oncology Pharmacy Resident and Juliana Leedy, PharmD, MS, Clinical Oncology Pharmacist, The University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama writes about nogapendekin alfa inbakicept-pmln.

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Tislelizumab-jsgr

Kristine Pisikian, PharmD, PGY-1 Pharmacist Resident and Caroline Quinn, PharmD, BCOP, Specialty Clinical Program Director at Prime Therapeutics write about Tislelizumab-jsgr.

Tools and Resources

Standardization of IDS Key Performance Indicators and Metrics; Results of a HOPA IDS SIG Survey

The Hematology/Oncology Pharmacy Association has helped establish practical guidance for Investigational Services metrics and site utilization.

X-ray of brain with desmoid tumors
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Nirogacestat (Ogsiveo)

Brooke Lochridge, PharmD ,PGY-2 Oncology Pharmacy Resident, of Tristar Centennial Medical Center, Nashville, TN, and Colleen McCabe, PharmD, BCOP, Oncology Clinical Specialist, Sarcoma & Melanoma from Vanderbilt University Medical Center, Nashville, TN w